Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.32% | +1.84% | -6.90% |
21/05 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
14/05 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.90% | 1.76TCr | |
+9.99% | 12TCr | |
+12.01% | 11TCr | |
-3.07% | 2.47TCr | |
-1.16% | 2.2TCr | |
-5.24% | 1.93TCr | |
-39.36% | 1.73TCr | |
+5.82% | 1.4TCr | |
+33.05% | 1.21TCr | |
+13.63% | 776.36Cr |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Transcript : BeiGene, Ltd. Presents at 4th Annual Guggenheim Oncology Day, Feb-10-2022 09